Aimovig: A Breakthrough Migraine Medication

Print icon

A new medication recently approved by the FDA for the prevention of migraine headache is offering promising results for patients who suffer from these debilitating headaches. Dr. Abigail Chua, a neurologist and headache specialist at the Hartford HealthCare Headache Center has more on this groundbreaking new therapy. 

Q: Tell us about the recent FDA-approved medication for migraine treatment.

A: Aimovig is a migraine treatment in a new class of medications called CGRP monoclonal antibodies. This medication has been FDA-approved for the preventive treatment of migraine, and acts by blocking the activity of calcitonin gene-related peptide, a molecule that is involved in migraine attacks.

Q: Why is this medication unique?

Prior to the development of CGRP-monoclonal antibodies, all of the preventives we were using for migraine were originally developed to treat other medical conditions, such as high blood pressure, depression, and epilepsy. While these medications can certainly be effective for a lot of people with migraine, not everyone can tolerate these medications, and some get no relief from them at all. Aimovig is the first medication available on the market that is designed to specifically target a protein that has been shown to be very closely tied to the development of migraine headaches.

Q: What type of patient would benefit most from this medication?

Patients who have migraine and have tried at least 2 other preventive treatments for migraine may be qualified to try this new medication.

Q: What kind of benefit can people expect from this new medication?

Aimovig is a migraine preventive treatment, and the goal of all migraine preventives is to decrease the frequency, severity, or duration of headaches. Depending on how often a person is having headaches, they may see a decrease in their headache frequency anywhere from 2 to 8 days per month, on average. Over the course of 12 months, this can mean 24 to 100 headache-free days per year.

For more information about the personalized migraine and head pain treatment available at Hartford HealthCare Headache Center, visit here


What's New


Tweeting for CME’s: The New Way to Earn Continuing Medical Education Hours

You’re a busy professional in the demanding field of healthcare. One of the demands on you is finding the time to take Continuing Medical Education (CME) hours to keep abreast of the latest innovations in healthcare – not to mention maintain your licensure and accreditation! Hartford HealthCare’s Department of Continuing...


Readers: What Would You Like to See in the Next Newsletter?

We hope you’re enjoying your email newsletter. Our goal each month is to give you a rich blend of topical health information, tips and commentary from our medical professionals and updates on some of the latest Hartford HealthCare medical news and services that might interest you. Let us know if...


Back to School, Back To Sports, Back to Concussion Prevention

It’s back-to-school time. For many kids, that also means back to a variety of sporting activities. But before your child takes to the field, keep in mind the potential injuries – especially concussions. Dr. Subramani (Manny) Seetharma is the medical director for the Hartford HealthCare Rehabilitation Network Concussion Clinic. Q:...


Chase Family Movement Disorder Center Expands to Plainfield

Patients with movement disorders in Eastern Connecticut now have a choice for comprehensive, specialized treatment close to home. Earlier this month, the Hartford HealthCare Chase Family Movement Disorders Center opened a new office at the Hartford HealthCare Health Center at  in Plainfield.  Along with the addition of the Plainfield facility, the...


New Haven Overdoses: Why K2 Is So Much More Dangerous Than Marijuana

A day after 76 overdoses on the New Haven Green attributed to a synthetic marijuana known as K2, officials responded to 19 more overdoses by late afternoon Thursday and warned that more drugs from the batch is still in the community. “’Synthetic marijuana’ is actually not marijuana at all,” says Dr....

Woman sitting at laptop.

How Linear Accelerator Technology Can Reduce Cancer Treatments

More than a year after being installed, Backus Radiation Oncology’s linear accelerator is being used in new ways to help patients fight cancer. In operation since last July, the new equipment uses a higher, more targeted dose of radiation for small tumors in various parts of the body. These precisely...

Elderly patient.

Geriatrician Joins Windham Hospital Staff

Geriatrician Mamta Singh is now accepting new patients at the Windham Hospital Family Health Center at 5 Founders St., Suite 100 in Willimantic. Her areas of interest include geriatric consultation, preventive health, cognitive decline in older adults, dementia, behavioral disturbances in advanced dementia, fall assessment, multiple morbidity and functional losses...